The Latest Cardiac and Vascular News
SAN FRANCISCO, Sept. 26, 2024 /PRNewswire/ — The Journal of Cardiac Failure has published data from the SCALE-HF 1 study on Bodyport Inc.’s, non-invasive biomarker guided technology, showing it predicts heart failure events at twice the rate of weight-based monitoring, with an average…
The Bodyport Cardiac Scale is available to monitor heart function and fluid status in a single step at home SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, a digital therapeutics company on a mission to address complex chronic conditions, announced today that its noninvasive biomarker […]
Seasoned healthcare executive added as Bodyport commercial efforts ramp up SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions, announced today the appointment of Jim Pursley to the company’s board of directors. “I […]
Medtech industry veteran to lead Bodyport market entry and growth of noninvasive tool to assess heart function and fluid status easily at home SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions, today announced the […]
SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, the digital health company focused on the detection and management of heart disease, today announced that it has named Amit Rushi as Chief Commercial Officer (CCO) and Phyllis Whiteley as Chair of the Board of Directors. With […]
Investments from Boehringer Ingelheim Venture Fund (BIVF), Playground Global and Initialized Capital will advance the prevention and management of heart disease SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, the digital health company focused on the detection and management of heart disease, today announced the […]
